Clopidogrel News
Pre-Thrombolysis Antiplatelet Therapy Enhances Ischemic Stroke ... - MedPage Today
The antiplatelet drugs used were aspirin (73%), a combination of aspirin and dipyridamole (24.7%), dipyridamole monotherapy (1.1%), and clopidogrel ...
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive ... - Lifescience-online
CURRENT is the only randomized controlled trial designed to investigate in 14000 patients, whether the use of a clopidogrel 600mg loading dose, ...
Patients, activists rally for removal of Chaiya - Bangkok Post
Saree Ongsomwang, manager of the Foundation for Consumers, said Mr Chaiya's decision to review the CL policy had delayed imports of heart drugs Clopidogrel ...
No easy way to predict which ACS patients will require CABG - TheHeart.Org
"In centers where most patients are taken to the cath lab within a couple of hours of presentation, it is entirely reasonable to leave clopidogrel until the ...
GPs keeping patients on clopiodrel longer than a year - Pulse
Uncertainty over how long patients should be on aspirin and clopidogrel after coronary stenting is leading GPs to ignore guidelines, suggests a new study. ...
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive ... - Juraforum.de
all 19 news articles
New drugs for NHF - Jamaica Gleaner
They are, respectively, Dalsan 20 milligram tablets; Aten 100 milligram tablets; Glimulin; and Clopidogrel-LAS 75 milligram tablets. ...
Patients Appear to be at Increased Risk of Adverse Events Within 3 ... - Newswise (press release)
Newswise — Patients who receive the anti-platelet medication clopidogrel following an acute coronary syndrome (such as heart attack) appear to be at greater ...
First 90 Days After Stopping Plavix Most Dangerous - U.S. News & World Report
The study does not address the issue of how long Plavix (clopidogrel) may safely be taken, said Ho, who is an assistant professor of medicine at the ...
Lilly and Daiichi Sankyo's prasugrel NDA gets priority review - Pharma Times (subscription)
The NDA for prasugrel, which if approved will compete with Plavix (clopidogrel), Sanofi-Aventis and Bristol-Myers Squibb’s blockbuster, was submitted to the ...
Clopidogrel RSS Feed